Though recent data shows a meaningful decrease in the U.S. adult obesity rate (37 percent in 2025 compared with a record high of 39.9 percent in 2022), the need for obesity treatments is still ...
Hosted on MSN
Wegovy pill launch promises change — but its cost and what it does could decide who gets help
The launch of the Wegovy pill is being hailed as a turning point in obesity treatment, offering the first tablet version of a drug that has already reshaped the global weight-loss market. Approved ...
Our collective appetite for weight loss drugs has become pretty much insatiable over the past few years. It’s thought that around 1.5 million people in the UK are on GLP-1 agonist medications to curb ...
With the U.S. Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the question arises whether other GLP-1 drugs will also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results